Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade D 149.0 -0.09% -0.14
PEN closed down 0.09 percent on Friday, September 13, 2019, on 1.4 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical PEN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.09%
NR7 Range Contraction -0.09%

Older signals for PEN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Medicine Health Health Care Interventional Radiology Stent Markets Medical Devices Aneurysm
Is PEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 185.7
52 Week Low 110.84
Average Volume 439,556
200-Day Moving Average 145.4152
50-Day Moving Average 156.8462
20-Day Moving Average 142.673
10-Day Moving Average 141.935
Average True Range 5.7858
ADX 25.66
+DI 26.8978
-DI 23.9786
Chandelier Exit (Long, 3 ATRs ) 133.0526
Chandelier Exit (Short, 3 ATRs ) 148.6624
Upper Bollinger Band 151.6262
Lower Bollinger Band 133.7198
Percent B (%b) 0.85
BandWidth 12.550658
MACD Line -2.8878
MACD Signal Line -4.6277
MACD Histogram 1.7399
Fundamentals Value
Market Cap 5.04 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 993.33
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 152.54
Resistance 3 (R3) 152.62 151.51 151.95
Resistance 2 (R2) 151.51 150.61 151.48 151.75
Resistance 1 (R1) 150.26 150.05 150.89 150.18 151.56
Pivot Point 149.15 149.15 149.47 149.12 149.15
Support 1 (S1) 147.90 148.25 148.53 147.82 146.44
Support 2 (S2) 146.79 147.69 146.76 146.25
Support 3 (S3) 145.54 146.79 146.05
Support 4 (S4) 145.46